MacroGenics
MGNX
#9151
Rank
NZ$0.19 B
Marketcap
NZ$3.04
Share price
-5.18%
Change (1 day)
-43.59%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.19 Billion

As of February 2026 MacroGenics has a market cap of NZ$0.19 Billion. This makes MacroGenics the world's 9151th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.19 B9.3%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of MacroGenics was reported to be:

NZ$0.19 Billion
by Nasdaq info icon info icon
NZ$0.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$249.60 B 129,760.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.543 T 803,057.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.67 B 158,927.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$292.45 B 152,049.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$457.32 B 237,826.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$186.07 B 96,708.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.43 B 645.79%๐Ÿ‡บ๐Ÿ‡ธ USA